hydroxyproline has been researched along with geranylgeranylacetone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujibayashi, T; Hasegawa, Y; Hashimoto, N; Ishiguro, N; Jijiwa, M; Kojima, T | 1 |
| Chen, B; Chen, J; He, W; Qi, L; Shao, D; Wang, L; Wang, M; Zhuang, Y | 1 |
2 other study(ies) available for hydroxyproline and geranylgeranylacetone
| Article | Year |
|---|---|
Protective effect of geranylgeranylacetone, an inducer of heat shock protein 70, against drug-induced lung injury/fibrosis in an animal model.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Apoptosis; Bleomycin; Bronchoalveolar Lavage Fluid; Chemokine CXCL2; Disease Models, Animal; Diterpenes; Dose-Response Relationship, Drug; HSP70 Heat-Shock Proteins; Hydroxyproline; Lung; Lung Injury; Mice; Mice, Inbred C57BL; Pulmonary Fibrosis | 2009 |
Geranylgeranylacetone attenuates hepatic fibrosis by increasing the expression of heat shock protein 70.
Topics: Actins; Alanine Transaminase; Animals; Aspartate Aminotransferases; Bilirubin; Carbon Tetrachloride; Disease Models, Animal; Diterpenes; HSP70 Heat-Shock Proteins; Hydroxyproline; Liver; Liver Cirrhosis; Male; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1; Up-Regulation | 2015 |